CORE1: Phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).

被引：0
|
作者：
Rixe, Olivier [1 ]
Castonguay, Vincent [2 ]
Conter, Henry [3 ]
Chalas, Eva [4 ]
Desai, Pratibha
Squillante, Christian [5 ]
MacDonald, Lisa A. [6 ]
Conlon, Rebekah [6 ]
Bramhecha, Yogesh [6 ]
Hirsch, Heather [6 ]
Graff, Jeremy R. [6 ]
Fiset, Stephan [7 ]
机构：
[1] Quantum Santa Fe, Santa Fe, NM USA
[2] Univ Laval, CRCHU Quebec, Quebec City, PQ, Canada
[3] William Osler Hlth Syst, Brampton, ON, Canada
[4] NYU Langone Hosp, Perlmutter Canc Ctr, Mineola, NY USA
[5] Allina Hlth, Minneapolis, MN USA
[6] IMV Inc, Dartmouth, NS, Canada
[7] IMV Inc, Quebec City, PQ, Canada
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT036
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Intravesical Thalidomide boosts bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer treatment
    Passos, Gabriela R.
    Camargo, Juliana A.
    Ferrari, Karen L.
    Saad, Mario J. A.
    de Mattos, Amilcar C.
    Reis, Leonardo O.
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [32] SINGLE INSTILLATION OF MITOMYCIN C (MMC) PLUS BACILLUS CALMETTE-GUERIN (BCG) VERSUS BCG ALONE IN HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Weiss, Brian
    Wein, Alan
    Malkowicz, S. Bruce
    Guzzo, Thomas
    JOURNAL OF UROLOGY, 2015, 193 (04): : E294 - E294
  • [33] Real-world treatment patterns among patients with non-muscle invasive bladder cancer (NMIBC) treated with intravesical Bacillus Calmette-Guerin (BCG)
    Kumar, Neela
    Balaji, Hiremagalur Parthasarathy
    Emond, Bruno
    Manceur, Ameur M.
    Ghelerter, Isabelle
    Pilon, Dominic
    Lefebvre, Patrick
    Imran, Nida Shafaat
    Ellis, Lorie
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 404 - 404
  • [34] Protocol for phase I study of pembrolizumab in combination with Bacillus Calmette-Guerin for patients with high-risk non-muscle invasive bladder cancer
    Jamil, Marcus L.
    Deebajah, Mustafa
    Sood, Akshay
    Robinson, Kathy
    Rao, Krishna
    Sana, Sherjeel
    Alanee, Shaheen
    BMJ OPEN, 2019, 9 (07):
  • [35] RE-EVALUATION OF INTRAVESICAL GEMCITABINE IN BACILLUS CALMETTE-GUERIN UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Escano, Manuel R. De Jesus
    Vertosick, Emily
    Benfante, Nicole
    Lenis, Andrew T.
    Reisz, Peter A.
    Goh, Alvin
    Cha, Eugene
    Donahue, Timothy F.
    Bochner, Bernard H.
    Sjoberg, Dan
    Pietzak, Eugene J.
    JOURNAL OF UROLOGY, 2021, 206 : E299 - E299
  • [36] Impact of bladder cancer family history on the prognosis of patients with non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG)
    Abou Chakra, Mohamad
    Duquesne, Igor
    Peyromaure, Michael
    Mott, Sarah L.
    Moussa, Mohamad
    O'Donnell, Michael A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (03) : 315 - 324
  • [37] LONG-TERM COST-EFFECTIVENESS OF NADOFARAGENE FIRADENOVEC AND OPORTUZUMAB MONATOX FOR TREATMENT OF BACILLUS CALMETTE-GUERIN (BCG)-UNRESPONSIVE, NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Joshi, M.
    Atlas, S. J.
    Rind, D. M.
    Beinfeld, M.
    McKenna, A.
    Patel, S.
    Chapman, R. H.
    Pearson, S.
    Touchette, D.
    VALUE IN HEALTH, 2021, 24 : S33 - S33
  • [38] Outcomes of Patients with Bacillus Calmette-Guerin (BCG)-Unresponsive Non-Muscle Invasive Bladder Cancer as Defined by the U.S. Food and Drug Administration
    Howard, Jeffrey M.
    Cook, Grayden S.
    Tverye, Aaron
    Nandy, Karabi
    Margulis, Vitaly
    Woldu, Solomon L.
    Lotan, Yair
    BLADDER CANCER, 2022, 8 (03) : 303 - 314
  • [39] Pembrolizumab with favezelimab or vibostolimab for patients with High-Risk (HR) bacillus Calmette-Guerin (BCG)-unresponsive Non-Muscle-Invasive Bladder Cancer (NMIBC): Phase 2 KEYNOTE-057 cohort C
    Necchi, A.
    Shore, N. D.
    Gupta, S.
    Kulkarni, G.
    Dave, H.
    Kapadia, E.
    Zhao, Q.
    Kamat, A.
    EUROPEAN UROLOGY, 2023, 83 : S748 - S748
  • [40] Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer
    Wang, Ziting
    So, Wei Zheng
    Loh, Kep Yong
    Lim, Yew Koon
    Mahendran, Ratha
    Wu, Qing Hui
    Chiong, Edmund
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (08) : 807 - 815
12345